NANOG and cancer: To determine whether the RA/MG132 combination alters the population of stem-like cells of neuroblastomas, we analysed the expression of stem cell-related markers such as Oct4, Nanog and Sox2 which are key regulators of embryonic stem cell maintenance [43] and are overexpressed in different cancers, including neuroblastoma [44].